Unlock growth in underleveraged pharma brands by optimizing portfolios, refreshing value propositions, targeting extra-urban markets via hub-and-spoke models, enhancing field force productivity, and leveraging digital strategies.

Revitalise underperforming pharma brands with data-driven strategies, rural market expansion, SKU rationalisation, P&L optimisation, and enhanced field force productivity to boost growth and profitability.